FAQ/Help |
Calendar |
Search |
Today's Posts |
10-22-2012, 09:01 AM | #1 | |||
|
||||
In Remembrance
|
this also has some good sources in the citations BTW
from http://www.hdsa.org/research/news/re...yleneblue.html The history of methylene blue as a potential treatment for Alzheimer’s disease: Looking at the progress of methylene blue as a potential treatment in Alzheimer’s may tell us something about how this compound could move through the HD pipeline of potential treatments. The Alzheimer’s community was electrified by a report from the 2008 International Conference on Alzheimer’s Disease that Alzheimer’s patients in a Phase IIb study showed an improvement in cognition after 6 months and a slowing of disease progression by 81 percent over a one year period. The research was carried out by Dr. Claude Wischik and his team at the University of Aberdeen. Dr. Wischik, Dr. K.M. Seng, the University of Aberdeen and investors formed TauRx to develop tau inhibitors as treatments for neurodegenerative diseases. The researchers used a version of methylene blue trademarked as Rember. Recently, TauRx has reported on its website that it has developed a second generation tau aggregation inhibitor also based on methylene blue. They claim that the chemically optimized inhibitor, called LMTX, has better tolerability and bioavailability. They are now planning a Phase III trial in the U.S. and Europe for mild and moderate Alzheimer’s and researching the possibility that the drug might treat Parkinson’s patient. Just as this article was being written, the company announced an international trial for Frontotemporal dementia, also called Pick’s disease. Huntington’s disease is not mentioned on the website but the company may be interested now that the research by Dr. Thompson and her colleagues has been reported.
__________________
Born in 1953, 1st symptoms and misdiagnosed as essential tremor in 1992. Dx with PD in 2000. Currently (2011) taking 200/50 Sinemet CR 8 times a day + 10/100 Sinemet 3 times a day. Functional 90% of waking day but fragile. Failure at exercise but still trying. Constantly experimenting. Beta blocker and ACE inhibitor at present. Currently (01/2013) taking ldopa/carbadopa 200/50 CR six times a day + 10/100 form 3 times daily. Functional 90% of day. Update 04/2013: L/C 200/50 8x; Beta Blocker; ACE Inhib; Ginger; Turmeric; Creatine; Magnesium; Potassium. Doing well. |
|||
Reply With Quote |
"Thanks for this!" says: | imark3000 (10-22-2012), lurkingforacure (10-22-2012) |
10-22-2012, 09:18 AM | #2 | |||
|
||||
In Remembrance
|
__________________
Born in 1953, 1st symptoms and misdiagnosed as essential tremor in 1992. Dx with PD in 2000. Currently (2011) taking 200/50 Sinemet CR 8 times a day + 10/100 Sinemet 3 times a day. Functional 90% of waking day but fragile. Failure at exercise but still trying. Constantly experimenting. Beta blocker and ACE inhibitor at present. Currently (01/2013) taking ldopa/carbadopa 200/50 CR six times a day + 10/100 form 3 times daily. Functional 90% of day. Update 04/2013: L/C 200/50 8x; Beta Blocker; ACE Inhib; Ginger; Turmeric; Creatine; Magnesium; Potassium. Doing well. |
|||
Reply With Quote |
"Thanks for this!" says: | moondaughter (10-22-2012) |
10-22-2012, 12:05 PM | #3 | |||
|
||||
Member
|
Quote:
an excerpt from the above article duly noted: Much of the emerging works in homeopathy has come out of Europe, relating to the use of nosodes and various other new preparations - gemnotherapy, oligotherapy, lithotherapy, and organotherapy - using homeopathic low potencies. It began as the use of Schussler's tissue salts as micro-dose nutrient therapy. This led the new biotherapies* in France and Germany where it is best-known form is homotoxicology of the Reckeweg system. They work more in the way of therapies for regeneration and detoxification at the cellular and tissue level than specific homeopathics. Tautopathy (Tauto-same), for example, is a method of curing or removing side effects of drugs by iso-intoxication, i. e., curing by means of the identical harmful agent in potentised form. Recent Russian research has confirmed this principle.
__________________
Smooth seas do not make skillful sailors.... Nature loves courage. “The day science begins to study non-physical phenomena, it will make more progress in one decade than in all the previous centuries of its existence.” ~ Nikola Tesla |
|||
Reply With Quote |
10-22-2012, 02:38 PM | #4 | |||
|
||||
Member
|
Methylene Blue might be hazardous to those taking serotonin enhancing drugs but it doesn't say at what dose.
http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm#table |
|||
Reply With Quote |
10-25-2012, 09:20 AM | #5 | |||
|
||||
Member
|
Quote:
--- Abraham
__________________
Smooth seas do not make skillful sailors.... Nature loves courage. “The day science begins to study non-physical phenomena, it will make more progress in one decade than in all the previous centuries of its existence.” ~ Nikola Tesla |
|||
Reply With Quote |
"Thanks for this!" says: | olsen (10-25-2012) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Methylene Blue | Parkinson's Disease | |||
Drug "Rember" is methylene blue | Parkinson's Disease | |||
Methylene blue clinical trial in Canada... | Parkinson's Disease | |||
methylene blue | Parkinson's Disease | |||
Methylene Blue | Parkinson's Disease |